Stellus Capital Income PBDC, LLC

Stellus Capital Income PBDC, LLC

Stellus Capital Income PBDC, LLC is a business development company (BDC) structured as an externally managed closed-end fund, as noted in its regulatory filings. The firm originates from the Stellus Capital platform, which the Dallas Business Journal reported as having invested in over 100 middle-market companies since its founding (per Dallas Business Journal, 2022). Its common stock trades on the New York Stock Exchange under the ticker symbol PBDC. Strategy focuses on debt investments in lower-middle-market companies, including first-lien, second-lien, and unitranche loans. The BDC targets returns through current income rather than capital appreciation, as described in its publicly available filings. Geographically, the firm lends to companies across the United States, with portfolio positions spanning manufacturing, healthcare, business services, and technology sectors. One known portfolio company is U.S. Anesthesia Partners, as reported in a 2022 SEC filing. The Stellus Capital platform, which includes other BDCs such as Stellus Capital Investment Corporation (NYSE: SCM), manages over $1 billion in assets across its funds, as disclosed in investor presentations (per the firm, 2023). No recent operational events for Stellus Capital Income PBDC, LLC were identified in public sources. Stellus Capital Income PBDC, LLC is distinct because it operates as a BDC rather than a traditional family office or private fund, offering public investors access to middle-market private credit. Its mandate focuses on income generation, which shapes its investment posture toward secured, cash-flow-generating debt.